Exjade

Medicinal product

(Invented) name

Exjade

Active substance (s)

Deferaziroksas

Strength

125 mg

Pharmaceutical form

disperguojamosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V03AC03, Deferasirox

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2006-08-28

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Dispersible tablet	1 vnt.
Deferaziroksas	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
25485	28091	1028091	lizdinė plokštelė	N28		Receptinis	EU/1/06/356/001	Netiekiama	-	-	No	-	-
25486	28092	1028092	lizdinė plokštelė	N84		Receptinis	EU/1/06/356/002	Netiekiama	-	-	No	-	-
42811	56579	1056579	lizdinė plokštelė	N252		Receptinis	EU/1/06/356/007	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-01-24	Išregistruotas
2006-08-28	Registruotas